LQDA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LQDA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Liquidia's Cash Ratio for the quarter that ended in Dec. 2024 was 4.22.
Liquidia has a Cash Ratio of 4.22. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Liquidia's Cash Ratio or its related term are showing as below:
During the past 9 years, Liquidia's highest Cash Ratio was 10.60. The lowest was 0.11. And the median was 4.51.
The historical data trend for Liquidia's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liquidia Annual Data | |||||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||||||
Cash Ratio | Get a 7-Day Free Trial |
![]() |
5.56 | 7.85 | 10.60 | 4.51 | 4.22 |
Liquidia Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Cash Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
4.51 | 7.20 | 5.50 | 6.04 | 4.22 |
For the Biotechnology subindustry, Liquidia's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Liquidia's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Liquidia's Cash Ratio falls into.
The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.
Liquidia's Cash Ratio for the fiscal year that ended in Dec. 2024 is calculated as:
Cash Ratio (A: Dec. 2024 ) | = | Cash, Cash Equivalents, Marketable Securities | / | Total Current Liabilities |
= | 176.479 | / | 41.781 | |
= | 4.22 |
Liquidia's Cash Ratio for the quarter that ended in Dec. 2024 is calculated as:
Cash Ratio (Q: Dec. 2024 ) | = | Cash, Cash Equivalents, Marketable Securities | / | Total Current Liabilities |
= | 176.479 | / | 41.781 | |
= | 4.22 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liquidia (NAS:LQDA) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Thank you for viewing the detailed overview of Liquidia's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Jason Adair | officer: V.P. Crp Dvlpmnt and Strtgy | C/O LIQUIDIA TECHNOLOGIES, INC., 419 DAVIS DRIVE, SUITE 100, MORRISVILLE NC 27560 |
Rajeev Saggar | officer: Chief Medical Officer | 419 DAVIS DRIVE, SUITE 100, MORRISVILLE NC 27560 |
Scott Moomaw | officer: SVP, Commercial | P.O. BOX 110085, RESEARCH TRIANGLE PARK NC 27709 |
Michael Kaseta | officer: Chief Financial Officer | 7100 WEST CREDIT AVENUE, SUITE 101, MISSISSAUGA A6 L5N OE4 |
Russell Schundler | officer: General Counsel | P.O. BOX 110085, RESEARCH TRIANGLE PARK NC 27709 |
Roger Jeffs | director | |
Paul B Manning | director, 10 percent owner | 200 GARRETT STREET SUITE S, CHARLOTTESVILLE VA 22902 |
Caligan Partners Lp | director, 10 percent owner, other: See Remarks | 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022 |
Robert A Lippe | officer: Chief Operations Officer | C/O ALEXZA PHARMACEUTICALS, INC., 2091 STIERLIN COURT, MOUNTAIN VIEW CA 94043 |
Arthur S Kirsch | director | 7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4 |
David Edward Johnson | 10 percent owner | 590 MADISON AVENUE, NEW YORK NY 10022 |
Raman Singh | director | C/O LIQUIDIA TECHNOLOGIES, INC., 419 DAVIS DRIVE, SUITE 100, MORRISVILLE NC 27560 |
Katherine Rielly-gauvin | director | 419 DAVIS DRIVE, MORRISVILLE NC 27560 |
Stephen M Bloch | director | 285 RIVERSIDE AVENUE, SUITE 250, WESTPORT CT 06880 |
Joanna Horobin | director | 215 FIRST STREET, SUITE 440, CAMBRIDGE MA 02142 |
From GuruFocus
By GuruFocus News • 03-19-2025
By Marketwired • 03-19-2025
By PRNewswire • 11-02-2024
By Marketwired • 11-12-2024
By GuruFocus News • 11-14-2024
By PRNewswire • 10-03-2024
By GuruFocus News • 03-20-2025
By GuruFocus News • 03-20-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.